Laddar...

Factor XIa inhibitors: A review of patent literature

INTRODUCTION: Anticoagulants are the mainstay for prevention and/or treatment of thrombotic disorders. Each clinically used anticoagulant is associated with significant adverse consequences, especially bleeding. Factor XIa (FXIa), a key factor involved in the amplification of procoagulation signal,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Expert Opin Ther Pat
Huvudupphovsmän: Al-Horani, Rami A., Desai, Umesh R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941829/
https://ncbi.nlm.nih.gov/pubmed/26881476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543776.2016.1154045
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!